NO985891D0 - Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler - Google Patents

Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler

Info

Publication number
NO985891D0
NO985891D0 NO985891A NO985891A NO985891D0 NO 985891 D0 NO985891 D0 NO 985891D0 NO 985891 A NO985891 A NO 985891A NO 985891 A NO985891 A NO 985891A NO 985891 D0 NO985891 D0 NO 985891D0
Authority
NO
Norway
Prior art keywords
anticonvulsants
benzamide derivatives
substituted benzamide
substituted
derivatives
Prior art date
Application number
NO985891A
Other languages
English (en)
Norwegian (no)
Other versions
NO985891L (no
Inventor
John David Harling
Barry Sidney Orlek
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612608.1A external-priority patent/GB9612608D0/en
Priority claimed from GBGB9615352.3A external-priority patent/GB9615352D0/en
Priority claimed from GBGB9711013.4A external-priority patent/GB9711013D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO985891L publication Critical patent/NO985891L/no
Publication of NO985891D0 publication Critical patent/NO985891D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO985891A 1996-06-17 1998-12-16 Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler NO985891D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9612608.1A GB9612608D0 (en) 1996-06-17 1996-06-17 Novel compounds
GBGB9615352.3A GB9615352D0 (en) 1996-07-22 1996-07-22 Novel compounds
GBGB9711013.4A GB9711013D0 (en) 1997-05-28 1997-05-28 Novel compounds
PCT/EP1997/003131 WO1997048683A1 (en) 1996-06-17 1997-06-13 Substituted benzamide derivatives and their use as anticonvulsants

Publications (2)

Publication Number Publication Date
NO985891L NO985891L (no) 1998-12-16
NO985891D0 true NO985891D0 (no) 1998-12-16

Family

ID=27268330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985891A NO985891D0 (no) 1996-06-17 1998-12-16 Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler

Country Status (14)

Country Link
US (1) US6110934A (cs)
EP (1) EP0906283A1 (cs)
AR (1) AR008234A1 (cs)
AU (1) AU729124B2 (cs)
BR (1) BR9709906A (cs)
CA (1) CA2258238A1 (cs)
CZ (1) CZ416498A3 (cs)
HU (1) HUP9902166A3 (cs)
IL (1) IL127068A0 (cs)
NO (1) NO985891D0 (cs)
NZ (1) NZ332757A (cs)
PL (1) PL330465A1 (cs)
TR (1) TR199802745T2 (cs)
WO (1) WO1997048683A1 (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010016657A1 (en) 1997-03-18 2001-08-23 Smithkline Beecham P.L.C. Substituted isoquinoline derivatives and their use as anticonvulsants
DZ2446A1 (fr) * 1997-03-18 2003-01-11 Smithkline Beecham Plc Nouveaux composés
GB9726695D0 (en) 1997-12-17 1998-02-18 Smithkline Beecham Plc Novel compounds
KR100568654B1 (ko) * 1997-03-18 2006-04-07 스미스클라인비이참피이엘시이 치환된 이소퀴놀린 유도체 및 진경제로서의 그의 용도
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
GB9816984D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
GB9817424D0 (en) 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
EP2033953A1 (en) * 2002-02-15 2009-03-11 Glaxo Group Limited Vanilloid receptor modulators
GB0210762D0 (en) * 2002-05-10 2002-06-19 Glaxo Group Ltd Compounds
PT1632477T (pt) 2003-06-12 2017-04-04 Astellas Pharma Inc Derivado de benzamida ou seu sal
MXPA06008201A (es) * 2004-01-23 2006-08-31 Amgen Inc Ligandos del receptor de vanilloide y su uso en tratamientos.
JP5306986B2 (ja) * 2006-03-16 2013-10-02 エボテック (ユーエス) インコーポレイテッド P2x7調節因子としてのビシクロへテロアリール化合物およびその使用
ATE504586T1 (de) 2006-08-01 2011-04-15 Glaxo Group Ltd Pyrazoloä3,4-büpyridinverbindungen und ihre verwendung als pde4-inhibitoren
US11787767B2 (en) 2020-04-17 2023-10-17 Escient Pharmaceuticals, Inc. Modulators of mas-related g-protein receptor X4 and related products and methods
CN117285463A (zh) * 2023-09-04 2023-12-26 南通敏言生物医药科技有限公司 一种5-氨基-8-溴-2-叔丁氧羰基-1,2,3,4-四氢异喹啉的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634851A (cs) * 1963-05-15 1900-01-01
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
PL330465A1 (en) 1999-05-24
CA2258238A1 (en) 1997-12-24
NO985891L (no) 1998-12-16
NZ332757A (en) 1999-06-29
AU729124B2 (en) 2001-01-25
HUP9902166A2 (hu) 1999-10-28
TR199802745T2 (xx) 1999-04-21
AR008234A1 (es) 1999-12-29
WO1997048683A1 (en) 1997-12-24
HUP9902166A3 (en) 2001-01-29
BR9709906A (pt) 1999-08-10
AU3259597A (en) 1998-01-07
CZ416498A3 (cs) 1999-06-16
IL127068A0 (en) 1999-09-22
US6110934A (en) 2000-08-29
EP0906283A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
NO972983L (no) Sulfonamider og deres anvendelse
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
NO973338D0 (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
NO20012688D0 (no) Benzamidderivater og anvendelse derav som APOB-100 sekresjonsinhibitorer
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20020383D0 (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK1012137T3 (da) Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
NO994510D0 (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
DK0770059T3 (da) Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler
NO981121L (no) Substituerte aminoforbindelser og deres anvendelse som analgetisk virksomme stoffer
DK0839146T3 (da) Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
DK0764157T3 (da) Benzopyraner og deres anvendelse som terapeutiske midler
FI964031L (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application